share_log

Sanofi (EPA:SAN) Stock Passes Below Two Hundred Day Moving Average of $86.52

Sanofi (EPA:SAN) Stock Passes Below Two Hundred Day Moving Average of $86.52

賽諾菲(EPA:SAN)股票低於 86.52 美元的兩百日移動平均線
Defense World ·  2023/02/07 03:22

Sanofi (EPA:SAN – Get Rating) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of €86.52 ($93.03) and traded as low as €82.25 ($88.44). Sanofi shares last traded at €85.14 ($91.55), with a volume of 4,394,526 shares traded.

賽諾菲(EPA:SAN-獲得評級)股票在週一交易期間低於其 200 天移動平均線。該股票的交易價格為 200 歐元(93.03 美元),交易價格低至 82.25 歐元(88.44 美元)。賽諾菲股票的最後交易價格為 85.14 歐元(91.55 美元),交易量為 4,394,526 股。

Sanofi Stock Down 0.3 %

賽諾菲股票下降 0.3%

The company's fifty day simple moving average is €89.56 and its two-hundred day simple moving average is €86.52.

該公司的五十天簡單移動平均線為 89.56 歐元,其 200 天簡單移動平均線為 86.52 歐元。

Sanofi Company Profile

賽諾菲公司簡介

(Get Rating)

(取得評分)

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products.

賽諾菲與其子公司一起在美國,歐洲和國際上從事治療解決方案的研究,開發,製造和營銷。它通過三個部分運作:藥品,疫苗和消費者保健。公司提供專業護理產品,包括人類單克隆抗體;多發性硬化症、神經病學、其他炎症性疾病、免疫學、罕見疾病、腫瘤學和罕見血液疾病的產品;糖尿病藥物;心血管和既定的處方產品。

Further Reading

進一步閱讀

  • Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
  • Can Cummins Power To A New High?
  • How to Find Penny Stocks to Invest and Trade
  • ONSemi Is Marching Higher On Great Results
  • What Tyson Foods Q1 Means For Staples Stocks
  • 勁量控股有限公司; 失去電力或電氣化時間購買?
  • 康明斯力量可以達到新高嗎?
  • 如何找到便士股進行投資和交易
  • OnSEMI 在偉大的結果上更高的行進
  • 泰森食品 Q1 對斯台普斯股票意味著什麼

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.

接收賽諾菲日報的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Sanofi 及相關公司的最新新聞和分析師評級的簡明每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論